Applications of Affinity Binding to the Development of Heparin Removing and Sensing Devices

  • Shu-Ching Ma
  • Victor C. Yang


Affinity binding between a specific ligand and a receptor has been widely used in the development of immunoassays, purification of biological materials, and fabrication of biosensors. Because of the high specificity in the interaction between a receptor (e. g., antibody, binding protein, etc.) and its ligand, a sensing or purifying system thus developed would normally possess unique selectivity. In this chapter, we will discuss the applications of the affinity approach to the development of a heparin removal system and two heparin sensing devices (one is a disposable paper strip, and the other is a probe-type heparin electrode). These systems are established utilizing the specific binding of heparin either with its clinical antagonist (i. e., protamine) or with a strong heparin-complexing reagent, tridodecylmethylammonium chloride (TDMAC). These devices should be of significant value because they can improve the safety of current extracorporeal blood circulation (ECBC) procedures or provide a safeguard to heparin therapy.


Hollow Fiber Paper Strip Protamine Sulfate Cyanate Ester Mixed Venous Oxygen Saturation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Arnold, M. A., and Meyerhoff, M. E., 1988, Recent advances in the development and analytical applications of biosensors, CRC Crit. Rev. Anal. Chem. 20:149–196.CrossRefGoogle Scholar
  2. Bernstein, H., Yang, V. C., Lund, D., Randhawa, M., Harmon, W., and Langer, R., 1987, Extracorporeal enzymatic heparin removal: Use in a sheep dialysis model, Kidney Int. 32:452–463.PubMedCrossRefGoogle Scholar
  3. Bradford, M. M., 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254.PubMedCrossRefGoogle Scholar
  4. Chen, W., and Yang, V. C., 1991, Versatile, non-clotting-based heparin assay requiring no instrumentation, Clin. Chem. 37:832–837.PubMedGoogle Scholar
  5. Craggs, A., Moody, G. J., and Thomas, J. D. R., 1974, PVC matrix membrane ion-selective electrodes, J. Chem. Educ. 51:541–544.CrossRefGoogle Scholar
  6. Diederich, D A., Wiegmann, T. B., and Pinnick, R. V., 1985, Method for regional anticoagulation during extracorporeal dialysis. U.S. Patent 4,500,309.Google Scholar
  7. Gott, V. L., 1972, Heparinized shunts for thoracic vascular operations, Ann. Thoracic Surg. 14:219–220.CrossRefGoogle Scholar
  8. Grode, G. A., Falb, R. D., and Crowley, J. P., 1972, Biocompatible materials for use in the vascular system, J. Biomed. Mater. Res. Symp. 3:77–84.CrossRefGoogle Scholar
  9. Hartman, K., Luterotti, S., Osswald, H. F., Oehme, M., Meier, P. C., Ammann, D., and Simon, W., 1978, Chloride-selective liquid-membrane electrodes based on lipophilic methyl-tri-N-alkylammonium compounds and their applicability to blood serum measurements, Mikrochim. Acta 11:235–244.CrossRefGoogle Scholar
  10. Hirsh, J., 1984, Heparin induced bleeding, Nouv. Rev. Fr. Hematol. 26:262–266.Google Scholar
  11. Jaques, L. B., 1973, Protamine: Antagonist to heparin, Can. Med. Assoc. J. 108:1291–1297.PubMedGoogle Scholar
  12. Jaques, L. B., 1980, Heparins: Anionic polyelectrolyte drugs, Pharmacol. Rev. 31:99–165.Google Scholar
  13. Jaques, L. B., and Wollin, A., 1967, A modified method for the colorimetric determination of heparin, Can. J. Physiol. Pharmacol. 45:787–794.PubMedCrossRefGoogle Scholar
  14. Katz, N. M., Kim, Y. D., Siegelman, R., Ved, S. A., Ahned, S. W., and Wallace, R. B., 1987, Hemodynamics of protamine administration, J. Thoracic Cardiovasc. Surg. 94:881–886.Google Scholar
  15. Kelton, J. G., and Hirsh, J., 1984, Bleeding associated with antithrombotic therapy, Semin. Hematol. 17:375–379.Google Scholar
  16. Kim, J., Yang, A. J., and Yang, V. C., 1992, Protamine immobilization and heparin adsorption on the protamine-bound cellulose fiber membrane, Biotechnol. Bioeng. 39:450–456.PubMedCrossRefGoogle Scholar
  17. Kirklin, J. K., Chenoweth, D. E., Naftel, D. C., Blackstone, E. H., Kirklin, J. W., Bitran, D. D., Curd, J. G., Reves, J. G., and Samuelson, P. N., 1986, Effects of protamine administration after cardiopulmonary bypass on complement, blood components, and the hemodynamic state, Ann. Thoracic Surg. 41:193–199.CrossRefGoogle Scholar
  18. Kohn, J., and Wilchek, M., 1978, A colorimetric method for monitoring activation of Sepharose by cyanogen bromide, Biochem. Biophys. Res. Commun. 84:7–14.PubMedCrossRefGoogle Scholar
  19. Langer, R., Linhardt, R. L., Galliher, P. M., Flanagan, C. L., Cooney, C. L., and Klein, M. D., 1982, An enzymatic system for removing heparin in extracorporeal therapy, Science 217:261–263.PubMedCrossRefGoogle Scholar
  20. Ljungberg, B., Blomback, M., Johnsson, H., and Lins, L. E., 1987, A single dose of low molecular weight heparin fragment for anticoagulation during hemodialysis, Clin. Nephrol. 27:31–35.PubMedGoogle Scholar
  21. Ma, S., Meyerhoff, M. E., and Yang, V. C., 1992, Heparin responsive electrochemical sensor, Anal. Chem. 64:694–697.PubMedCrossRefGoogle Scholar
  22. Morel, D. R., Costabella, P. M. M., and Pittet, J. F., 1990, Adverse cardiopulmonary effects and increased plasma thromboxane concentrations following the neutralization of heparin with protamine in awake sheep are infusion rate-dependent, Anesthesiology 73:415–424.PubMedCrossRefGoogle Scholar
  23. Nojiri, C., Park, K. D., and Grainger, D. W., 1990, In vitro nonthrombogenicity of heparin immobilized polymer surfaces, Trans. Am. Soc. Artif. Intern. Organs 36:168–172.Google Scholar
  24. Oesch, U., Ammann, D., Pham, H. V., Wuthier, U., Zund, R., and Simon, W., 1986, Design of anion-selective membranes for clinically relevant sensors, J. Chem. Soc, Faraday Trans. 1 1986:1179–1186.CrossRefGoogle Scholar
  25. Olinger, G. N., Becker, R. M., and Bonchek, L. I., 1980, Noncardiogenic pulmonary edema and peripheral vascular collapse following cardiopulmonary bypass: Rare protamine reaction? Ann. Thoracic Surg. 29: 20–25.CrossRefGoogle Scholar
  26. Porter, J., and Jick, J., 1977, Drug-related deaths among medical inpatients, J. Am. Med. Assoc. 237:879–881.CrossRefGoogle Scholar
  27. Swartz, R. D., and Port, E K., 1979, Preventing hemorrhage in high risk hemodialysis: Regional versus low total dose heparin, Kidney Int. 16:513–518.PubMedCrossRefGoogle Scholar
  28. Walenga, J., Fareed, J., Hoppensteadt, D., and Emanuele, R. M., 1986, In vitro evaluation of heparin fractions: Old vs new methods. CRC Crit. Rev. Clin. Lab. Sci. 22:361–389.CrossRefGoogle Scholar
  29. Wegmann, D., Weiss, H., Ammann, D., Morf, W E., Pretsch, E., Sugahara, K., and Simon, W., 1984, Anionselective liquid membrane electrodes based on lipophilic quaternary ammonium compounds, Mikrochim. Acta III:1–16.CrossRefGoogle Scholar
  30. Weiler, J. M., Freiman, P., Sharath, M. D., Metzger, W. J., Smith, J. M., Richerson, H. B., Ballas, Z. K., Halverson, P. C., Shulan, D. D. J., Matsuo, S., and Wilson, R. L., 1985, Serious adverse reactions to protamine sulfate: Are alternatives needed? J. Allergy Clin. Immunol. 75:297–303.PubMedCrossRefGoogle Scholar
  31. Weiler, J. M., Cellhaus, M. A., Carter, J. G., Meng, R. L., Benson, P. M., Hottel, R. A., Schillig, K. B., Vegh, A.B., and Clarke, W. R., 1990. A prospective study of the risk of an immediate adverse reaction to protamine sulfate during cardiopulmonary bypass surgery, J. Allergy Clin. Immunol. 85:713–719.PubMedCrossRefGoogle Scholar
  32. Yang, V. C., 1989, Extracorporeal blood deheparinization system, U.S. Patent 4,800,016.Google Scholar
  33. Yang, V. C., Port, F. K., Kim, J. S., Teng, C. L. C., Till, G. O., and Wakefield, T. W., 1991, The use of immobilized protamine in removing heparin and preventing protamine-induced complications during extracorporeal blood circulation, Anesthesiology 75:288–297.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • Shu-Ching Ma
    • 1
  • Victor C. Yang
    • 1
  1. 1.College of PharmacyThe University of MichiganAnn ArborUSA

Personalised recommendations